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ABSTRACT
Objective The aim of the study is to assess changes 
in heart structure and function associated with heavy 
alcohol use by comparing echocardiographic indices in a 
population- based sample to those in patients admitted to 
an inpatient facility with severe alcohol problems.
Methods and results We used data from the Know 
Your Heart study (2015–2017) which is a cross- sectional 
study that recruited 2479 participants aged 35–69 years 
from the general population of the city of Arkhangelsk in 
Northwest Russia and 278 patients from the Arkhangelsk 
Regional Psychiatric Hospital with a primary diagnosis 
related to chronic alcohol use (narcology clinic subsample). 
The drinking patterns of the population- based sample 
were characterised in detail. We used regression models 
controlling for age, sex, smoking, education and waist to 
hip ratio to evaluate the differences in echocardiographic 
indices in participants with different drinking patterns. 
The means of left ventricular end- diastolic diameter 
and indexed left atrial systolic diameter were increased 
among heavy drinkers (narcology clinic subsample), while 
mean left ventricular ejection fraction was decreased in 
this group compared with the population- based sample. 
In contrast, the harmful and hazardous drinkers in the 
population- based sample did not differ from non- problem 
drinkers with respect to echocardiographic indices of 
systolic and diastolic function.
Conclusions Extremely heavy drinking is associated with 
a specific set of structural and functional abnormalities of 
the heart that may be regarded as precursors of alcohol- 
related dilated cardiomyopathy.
INTRODUCTION
Long- term heavy alcohol consumption is 
known to have a direct toxic effect on the 
heart that can ultimately result in clini-
cally diagnosed alcoholic cardiomyopathy.1 
However, there will be a continuum of 
changes in cardiac structure and function 
in response to heavy drinking which may or 
may not ultimately result in a diagnosis of 
cardiomyopathy per se. There have been very 
few studies of the possible spectrum of such 
pathophysiological changes despite the fact 
that they may in themselves increase the risk 
of serious cardiovascular events.
The most informative study to date was of 
nearly 50 000 Koreans who attended routine 
clinical health checks and had alcohol 
consumption recorded. In this study, heavy 
drinking (>60 g/day alcohol) was associated 
with increased odds of left ventricular enlarge-
ment, relative wall thickness changes and 
impaired left ventricular diastolic function 
(based on septal e′ velocity and E/e′ ratio).2 
A small Serbian study found no difference in 
left ventricular ejection fraction in 89 asymp-
tomatic alcoholic patients compared with 30 
participants with no alcohol problems.3
Key messages
What is already known about this subject?
 ► In some individuals, long- term heavy alcohol con-
sumption results in clinically diagnosed alcoholic 
cardiomyopathy.
What does this study add?
 ► This study characterised preclinical changes in 
heart structure and function in high- risk alcohol us-
ers using echocardiography.
 ► Two potential mechanisms are plausible based on 
observed changes: alcohol- related dilated cardio-
myopathy by toxic damage of the heart muscle 
that could, among other effects, predispose to atrial 
fibrillation and consequently stroke or heart failure.
 ► Our study provides insight into the underlying 
mechanisms that may explain the observed asso-
ciations between heavy drinking and cardiovascular 
mortality.
How might this impact on clinical practice?
 ► General practitioners and cardiologists should be 
more aware of alcohol as a risk factor for cardio-
vascular disease.
 ► Screening for alcohol abuse should be done even in 
patients without symptoms of heart failure.
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Most other population- based studies that have inves-
tigated echocardiographic characteristics of drinkers 
have been limited to participants who drank moderately 
(ranging from abstinence to drinking more 14 standard 
drinks a week). These have not found any consistent 
association of alcohol drinking with abnormalities of left 
ventricular structure and function.3–10 The Framingham 
Heart Study found some evidence that alcohol drinking 
could affect risk of atrial fibrillation via its impact on left 
atrial structure.11
Most previous studies measured exposure to alcohol 
in terms of average volume of ethanol consumed in a 
defined period (a month or a year). However, it may be 
the case that certain patterns of drinking (eg, episodic 
binges) are particularly harmful to the heart.1 Excessive 
alcohol consumption, especially characterised by heavy 
episodic drinking of spirits,12 13 is thought to contribute 
substantially to cardiovascular diseases (CVD) mortality 
in countries of Eastern Europe.14 15 It is hypothesised that 
in this context alcohol may contribute to CVD mortality 
through non- ischaemic pathways. This is consistent with 
previous results we have reported that found elevated 
levels of N- terminal pro- b- type natriuretic peptide 
(NT- proBNP) among harmful drinkers in Russia and 
in Northern Ireland.16 17 However, we are not aware of 
any studies that have looked at the relationship between 
pattern and volume of heavy alcohol consumption and 
subclinical abnormalities of cardiac structure.
In this paper, we address many of the limitations of 
previous work by studying echocardiographic indices 
of heart structure and function in a sample of patients 
admitted to a clinical facility with a primary diagnosis of 
severe alcohol problems in comparison with a population- 
based sample of adults from the Russian city of Arkhan-
gelsk with well- characterised drinking patterns.
METHODS
Study design
As part of the Know Your Heart (KYH) study, we recruited 
2479 participants from the general population of the city 
of Arkhangelsk in Northwest Russia in the years 2015–
2017. A detailed account of the rationale and description 
of the methodology of KYH has been published previ-
ously.18 At the same time, we recruited 278 patients from 
the Arkhangelsk Regional Psychiatric Hospital with a 
primary diagnosis related to chronic alcohol drinking.18 
The latter group is referred to subsequently as the 
narcology clinic subsample consistent with Russian termi-
nology.
Study participants
The general population sample from the city Arkhan-
gelsk was recruited at random (stratified by age, sex and 
district of residence) using the regional health insurance 
fund register as the sampling frame. Trained interviewers 
visited the addresses of the randomly selected residents 
and invited persons of the target age and sex at each 
address to take part in the study. When successful, an 
interview was conducted about the health and behav-
iours of the participant. The response rate was 68% of 
the addresses where contact with a person of the target 
age and sex was established and 96% of those interviewed 
took part in a subsequent health check at the polyclinic 
of the Northern State Medical University, Arkhangelsk.18 
As described elsewhere,16 a sample of heavy drinkers 
(narcology clinic subsample) was also recruited from the 
regional psychiatric hospital where they were undergoing 
detoxification as inpatients. A total of 278 patients were 
recruited out of 322 patients invited (85.4%).
In this study, we analysed data on 2345 participants from 
the general population in Arkhangelsk and 268 persons 
from the narcology clinic subsample who completed an 
echocardiographic examination during the health check.
Data and sample collection
The baseline interview was administered by a trained 
interviewer using a tablet computer- assisted personal 
interviewing device. For the general population sample, 
the interview was done in people’s homes. For the 
narcology clinic subsample, it was done at the hospital 
by the same set of trained interviewers. Information was 
collected on medical history and socioeconomic circum-
stances, education and lifestyle.
The subsequent health check at the university poly-
clinic comprised a physical examination (including 
blood pressure, height, waist and hip circumference, and 
weight), blood sample collection and echocardiography 
examination. All participants had a second interview at 
this stage that recorded medical history, use of medica-
tions, alcohol use and smoking.
Echocardiographic examination
Six trained specialists certified in ultrasound performed 
the transthoracic echocardiography (ECHO) in the left 
lateral decubitus position using a 1.5–3.6 MHz phased 
array sector transducer (Vivid q, GE Healthcare). ECHO 
was performed according to standardised protocol 
consisting of B- mode, M- mode as well as pulsed- wave, 
continuous- wave and colour Doppler assessments in the 
parasternal view and apical 4- chamber and 2- chamber 
views. If necessary, breath- hold was used to ensure image 
quality. Offline reading was performed using EchoPAC 
(v.113, GE- Vingmed AS, Horten, Norway) by three ECHO 
specialists (SM, AR and EV) who were blinded to clinical 
data on each participant. We assessed the reproducibility 
of offline measurements in 60 participants randomly 
selected at the initial analytical stage.
Outcome variables
Left ventricular (LV) and left atrial (LA) volumes were 
measured from the apical 2- chamber and 4- chamber 
views using the biplane Simpson’s technique and LV 
ejection fraction (LVEF) calculated.19 LV mass was esti-
mated from M- mode measurements according to current 
echocardiographic guidelines.19 Chamber volumes and 
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dimensions were indexed to body surface area,19 LV mass 
was indexed by height2.7.20
Doppler measurements of aortic, mitral, pulmonary 
and tricuspid valve flow were obtained according to 
current guidelines.21 Peak early diastolic mitral annulus 
velocity (e′) was calculated as the average of peak veloci-
ties measured at the septal and lateral annulus by pulsed 
wave tissue Doppler imaging (TDI), E/e′ ratio was calcu-
lated as the ratio of the mitral peak early diastolic filling 
velocity to mitral annular early diastolic velocity.21
Left ventricular hypertrophy (LVH) was defined by 
LV mass >50 g/m2.7 among men and >47 g/m2.7 among 
women.22 Systolic dysfunction was defined by LVEF 
<50%,22 increased indexed LV end- diastolic diameter 
was defined19 >3.1 cm/m2 among men and >3.2 cm/m2 
among women, and increased indexed LV end- diastolic 
volume22 was defined >75 mL/m2. Enlarged indexed LA 
volume21 was defined >34 mL/m2, enlarged indexed LA 
diameter19 >2.3 cm/m2.
Diastolic dysfunction was defined based on reference 
values for tricuspid regurgitation velocity (>2.8 m/s), 
peak early diastolic mitral annulus velocity e′ (septal <7 
cm/s or lateral <10 cm/s), E/e′ ratio (≥14), left atrial 
volume index (>34 mL/m2).21
Exposure variables
We defined two categorical exposure variables. The first 
was binary and divided the study group into those from 
the narcology clinic subsample and those from the general 
population sample. The second exposure variable further 
categorised the general population sample by drinking 
pattern of harmful, hazardous, non- problem drinkers, 
non- drinkers (never drinkers and ex- drinkers) based on 
self- report of various dimensions of alcohol consumption 
(online supplemental table 1, online supplemental figure 
1).16 The choice of drinking patterns as an exposure vari-
able rather than volume of alcohol consumption is justi-
fied because very heavy drinkers tend to under- report the 
amount of consumed alcohol.23
Covariates
Information was available on classical CVD risk factors, 
including those that are on the potential causal pathway 
between alcohol use and heart structure and function 
abnormalities. We adjusted for age, sex, smoking and 
education as potential confounders. Education was classi-
fied into four categories: incomplete secondary or lower; 
secondary or professional school (general secondary 
school and/or secondary technical school); incomplete 
higher or specialised secondary (college or university of 
up to 3 years); higher (university, 4–6 years). Smoking 
status was categorised as current smokers, ex- smokers 
and never- smokers. For current smokers, the number 
of cigarettes smoked was specified as 1–10/day, 11–20/
day, >20/day. Body mass index (BMI) was calculated as 
weight (kg) divided by height (m) squared. Waist to hip 
ratio (WHR) was the mean of two measurements of waist 
divided by the mean of two measurements of hip.
Potential mediators of alcohol use on heart structure 
and function included use of antihypertensive medi-
cations and systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) (mean of the second and third 
measurements) because blood pressure is known to 
increase as a consequence of alcohol use.24 We adjusted 
for this set of mediators separately to evaluate the medi-
ating role of blood pressure distinct from other possible 
mediators. Use of antihypertensives was determined 
based on medications reported by the participants if 
they could be classified as diuretics, beta- blocking agents, 
calcium channel blockers and agents operating on the 
renin- angiotensin system.
NT- proBNP was measured using a high sensitivity elec-
trochemiluminescence immunoassay (Roche Diagnostics 
GmbH, Hitachi, Japan) on a Cobas e411 analyser.
Statistical methods
To assess the association between patterns of alcohol use 
and cardiac structure and function, we compared the 
echocardiographic measurements of the narcology clinic 
with the general population sample. Next, we compared 
echocardiographic indices across the categories of 
alcohol consumption: (1) narcology clinic subsample; (2) 
general population sample, harmful drinking pattern; 
(3) general population sample, hazardous drinking 
pattern; (4) general population sample, non- problem 
drinkers; (5) general population sample, never drinkers; 
(6) general population sample, ex- drinkers. The means 
and proportions were calculated along with 95% CI 
adjusted for age, sex, operator, reader as least- square 
means (predicted population margins) computed using 
general linear regression or logistic regression models.
Multivariable adjusted general linear regression models 
were used to compare the means of echocardiographic 
indices across categories of alcohol consumption: model 
1 adjusted for age and sex; model 2 adjusted for poten-
tial confounders (age, sex, smoking, education, WHR). 
Model 3 additionally included possible mediators (SBP 
and DBP, use of blood pressure lowering medications). 
Ultrasound operators and readers of the echocardio-
graphic images were included into all models as fixed 
effects to control for potential systematic differences 
between them. Model assumptions were assessed by visual 
inspection of residual plots.
Statistical analysis was performed using SAS software 
V.9.4 (SAS Institute).
RESULTS
The participants from the narcology clinic were more 
often men than in the general population sample (76.8% 
vs 41.7%) and had lower mean age (48.5 vs 53.7 years). 
Table 1 shows the means and percentages for CVD risk 
factors in the narcology clinic subsample and general 
population sample (age- adjusted and sex- adjusted). The 
participants from the narcology clinic were more likely to 
be smokers and to be less educated. However, BMI, total 
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and low density lipoproteincholesterol, SBP and use of 
blood pressure lowering medications were higher among 
the general population.
Table 2 presents age- adjusted and sex- adjusted 
mean values of echocardiographic parameters. Some 
echocardiographic measurements were not technically 
possible in some participants, which resulted in different 
analytic samples for each outcome measure (from 2370 to 
2609 participants) (table 2). After controlling for poten-
tial confounders, mean LV end- diastolic diameter and 
Table 2 Echocardiographic indices in narcology clinic subsample and the general population sample










Left ventricular mass/h2.7, g/m2.7 16 45.58 (43.92 to 47.25) 45.31 (44.51 to 46.11) 0.728
Left ventricular end- diastolic volume biplane/bsa, mL/m2 255 42.65 (41.13 to 44.16) 41.6 (40.84 to 42.36) 0.134
Left ventricular end- diastolic diameter/bsa, cm/m2 16 2.87 (2.83 to 2.91) 2.75 (2.73 to 2.77) <0.001
Left atrial systolic diameter/bsa, cm/m2 30 2.11 (2.08 to 2.14) 2.01 (2.00 to 2.03) <0.001
Left ventricular ejection fraction biplane, % 255 54.04 (53.15 to 54.94) 55.94 (55.49 to 56.39) <0.001
Left atrial volume/bsa, mL/m2 52 25.88 (24.86 to 26.9) 25.56 (25.07 to 26.06) 0.506
Peak early diastolic mitral annulus velocity (average e′), 
(cm/s)
99 10.20 (9.88 to 10.53) 10.54 (10.38 to 10.70) 0.026
E/e′ 138 6.84 (6.53 to 7.16) 6.97 (6.82 to 7.13) 0.383
*Adjusted for age, sex, operator, reader.
bsa, body surface area.




sample, N=2345 P value*
% (N) men 76.8 (208) 41.7 (981) <0.001
Age (years), mean (SD, min, max) 48.5 (8.5, 35.1, 68.6) 53.7 (9.6, 35.3, 69.9) <0.001




Current drinkers† 0 100% 91.0% (89.0 to 92.0)
Current smoking 2 76.3% (69.9 to 81.8) 23.0% (21.3 to 24.9) <0.001
AUDIT score>=8 0 96.8% (93.2 to 98.5) 7.8% (6.5 to 9.3) <0.001
CAGE score>=2 0 90.1% (84.9 to 93.6) 11.1% (9.7 to 12.5) <0.001
Use of antihypertensive medication 0 21.0% (15.8 to 27.3) 35.4% (33.2 to 37.7) <0.001
BMI (kg/m2), mean 0 24.9 (24.2 to 25.7) 27.8 (27.4 to 28.2) <0.001
Waist to hip ratio, mean 0 0.88 (0.87 to 0.89) 0.88 (0.88 to 0.89) 0.292
Systolic blood pressure (mm Hg), mean 10 127.4 (124.7 to 130.1) 132.8 (131.5 to 134.1) <0.001
Diastolic blood pressure (mm Hg), mean 10 83.2 (81.5 to 84.8) 83.8 (83.0 to 84.6) 0.419
Ln- transformed NT- proBNP 19 4.95 (4.81 to 5.09) 4.42 (4.35 to 4.49) <0.001
NT- proBNP >125 pg/mL 19 55.99 (49.27 to 62.5) 28.35 (26.34 to 30.44) <0.001
Total cholesterol (mmol/L), mean 10 4.99 (4.83 to 5.15) 5.35 (5.27 to 5.42) <0.001
Low density lipoprotein cholesterol 
(mmol/L), mean
10 3.23 (3.1 to 3.36) 3.58 (3.52 to 3.65) <0.001
High density lipoprotein cholesterol 
(mmol/L), mean
10 1.46 (1.41 to 1.52) 1.44 (1.41 to 1.46) 0.283
No higher education 0 52.8% (46.6 to 59.0) 23.6% (21.9 to 25.4) <0.001
*Adjusted for age, sex.
†All participants from narcology clinic sample are current drinkers, but were not drinking during the period of admission to narcology clinic.
AUDIT, Alcohol Use Disorders Identification Test; BMI, body mass index; CAGE, Cut down, Annoyed, Guilty, Eye Opener; NT- proBNP, N- 
terminal pro- b- type natriuretic peptide.
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mean LA systolic diameter were larger in narcology clinic 
subsample compared with general population sample, but 
there was no difference in mean LV mass (table 3). While 
mean LV end- diastolic volume and mean LA volume 
were larger in narcology clinic subsample compared 
with general population sample, differences were not 
statistically significant after adjustment for confounders 
(table 3). Among functional measurements, mean LV 
ejection fraction in the narcology clinic subsample was 
lower than the general population sample, while mean 
peak early diastolic mitral annulus velocity (e′) and mean 
E/e′ ratio were the same as in the general population 
sample. Additional adjustment for SBP, DBP, and blood 
pressure lowering medication use as possible mediators 
did not substantially affect these findings (table 3). The 
same analysis stratified by sex has given similar results 
(online supplemental table 2). We did not find any differ-
ences in echocardiographic indices between harmful and 
hazardous drinkers in the general population and non- 
problem drinkers (online supplemental tables 3-4).
We also examined differences in echocardiographic 
parameters between the general population sample and 
the narcology clinic subsample by comparing the preva-
lence of dysfunction defined using normal value thresh-
olds. As shown in online supplemental table 5, these same 
patterns of association appeared as seen for the compar-
ison of means. The general population sample prevalence 
of increased LV end- diastolic volume was 0.2% (5), of 
increased LV end- diastolic diameter 5.4% (126), of LVH 
33.8% (790), while in the narcology clinic subsample, the 
prevalence of those were 0.8% (2), 9.0% (24) and 19.8% 
(53), respectively. Systolic dysfunction (LV ejection frac-
tion <50%) was present in 10.2% (215) of the general 
population sample and 14.6% (37) of the narcology clinic 
subsample. Enlarged LA volume was present in 12.1% 
(279) of the general population sample and 15.0% (40) 
of the narcology clinic subsample, increased LA diameter 
was present in 9.9% (230) of the general population, 
compared with 13.5% (36) of the narcology clinic subsa-
mple. There were 7 (2.7%) participants with probable 
and 1 (0.4%) with definite diastolic dysfunction in the 
narcology clinic subsample; and 80 (3.6%) with probable 
and 12 (0.6%) with definite diastolic dysfunction in the 
general population sample.
NT- proBNP was elevated above 125 pg/mL among 
41.35% (110) of the narcology clinic subsample partic-
ipants compared with 32.61% (763) of the general 
population sample. The mean levels of ln- transformed 
NT- proBNP controlled for age and sex were higher in the 
narcology clinic subsample compared with the general 
population sample (table 1). Finally, we examined the 
relationship between echocardiographic indices and 
NT- proBNP (online supplemental table 6). As expected, 
moderate correlations were found between echocardio-
graphic markers of cardiac remodelling and function, 
and NT- proBNP. The correlation was strongest for LV 
mass, LV end- diastolic diameter, LA left atrial systolic 
diameter, LA volume, E/e′.
Sensitivity analysis
Excluding never drinkers and ex- drinkers from the 
general population sample did not have any impact on 
the results (online supplemental table 7).
DISCUSSION
We found evidence of abnormalities in cardiac struc-
ture and function among heavy drinkers from a 
narcology clinic in Arkhangelsk (Russia) compared with 
the Arkhangelsk general population. Specifically, the 
narcology clinic subsample exhibited adverse LV remod-
elling (larger LV end- diastolic diameter and lower LV 
ejection fraction), which may indicate early signs of toxic 
dilated cardiomyopathy. The evidence regarding adverse 









Left ventricular mass/h2.7, g/m2.7 0.27 (−1.27 to 1.81) −0.25 (−1.81 to 1.31) 0.79 (−0.74 to 2.32)
Left ventricular end- diastolic volume biplane/bsa, mL/m2 1.04 (−0.32 to 2.41) 1.28 (−0.21 to 2.77) 1.83 (0.34 to 3.31)
Left ventricular end- diastolic diameter/bsa, cm/m2 0.12 (0.08 to 0.16) 0.07 (0.03 to 0.11) 0.07 (0.04 to 0.11)
Left atrial systolic diameter/bsa, cm/m2 0.09 (0.07 to 0.12) 0.07 (0.04 to 0.11) 0.08 (0.05 to 0.11)
Left ventricular ejection fraction biplane, % −1.90 (−2.70 to –1.09) −1.58 (−2.44 to 0.72) −1.56 (−2.43 to 0.7)
Left atrial volume/bsa, mL/m2 0.32 (−0.62 to 1.26) 0.60 (−0.42 to 1.62) 1.12 (0.10 to 2.14)
Peak early diastolic mitral annulus velocity (average e′) (cm/s) −0.34 (−0.64 to –0.04) −0.11 (−0.42 to 0.2) −0.15 (−0.45 to 0.15)
E/e′ −0.13 (−0.42 to 0.16) −0.14 (−0.45 to 0.18) 0.05 (−0.26 to 0.36)
*Model 1: Adjusted for age and sex. Model 2: Additionally adjusted for education and smoking, WHR. Model 3: Additionally adjusted for SBP, 
DBP, blood pressure medication. All models are adjusted for operator and reader.
†β, linear regression coefficient for the difference between narcology clinic subsample and general population sample (positive value 
indicates higher mean in the narcology clinic subsample).
bsa, body surface area; DBP, diastolic blood pressure; SBP, systolic blood pressure; WHR, waist to hip ratio.
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LA remodelling in the narcology clinic subsample (which 
may represent the sequelae of systolic and diastolic LV 
dysfunction) was equivocal: LA diameter was larger, but 
differences with the general population sample in LA 
volume were not statistically significant after adjustment 
for confounders. This may in part reflect the fact that in 
our study there may have been greater imprecision in 
the measurement of volume compared with diameter, 
leading to an artefactual attenuation in the strength of 
the true association. Diastolic dysfunction as measured by 
decreased peak early diastolic mitral annular velocity was 
observed in unadjusted models, but the regression coef-
ficients decreased to zero after adjustment for smoking, 
education and WHR. Ours is the largest study that has 
been able to compare various differences in cardiac struc-
ture and function among those with a clinical diagnosis 
of alcohol problems and a sample of the general popula-
tion stratified by drinking pattern.
In the population- based sample, we found no clear 
evidence for an association between patterns of alcohol 
consumption and echocardiographic indices of global 
left ventricular systolic and diastolic function.
Previous research
Our finding of increased LV end- diastolic diameter is 
consistent with the results of a large community- based 
study of nearly 50 000 participants conducted in Korea.2 
However, unlike this study where heavy drinking (more 
than 60 g of alcohol per day) was associated with increased 
odds of left ventricular hypertrophy and increase in E/e′ 
compared with abstainers, we did not observe increase in 
LV mass or E/e′.2 Also, we observed decreased LV ejec-
tion fraction in very heavy drinkers in our study, while 
the Korean study did not report findings on LV ejection 
fraction. Contrary to this, a small study of chronic asymp-
tomatic alcoholics found no differences in LV ejection 
fraction compared with those without alcohol problems.3
Apart from the studies mentioned above, the focus 
of most research on alcohol in relation to echocardio-
graphic indices was on moderate drinking. It is plau-
sible that it is only chronic heavy episodic drinking that 
gives rise to the detectable changes in cardiac structure 
or function. Nevertheless, for completeness, we note 
the following conclusions from the studies of moderate 
drinkers. Reduced LV ejection fraction among alcohol 
drinkers was found in some studies,4–7 but not in 
others.8–10 Similarly, the dimensions and mass of the left 
ventricle were found to be increased among drinkers in 
some studies4 8–10 not in all.6 LA dimensions and indices 
of diastolic dysfunction were increased among drinkers 
in some studies,4 9 11 but not in others.6 8 10
Clinical implications
The adverse LV remodelling we observed in the narcology 
subsample may represent a subclinical end of the spec-
trum of dilated cardiomyopathy, which is associated with 
an increased risk of ventricular arrhythmia. This finding 
is also supported by elevated NT- proBNP, a marker of 
cardiac wall stretch, in the narcology clinic subsample 
compared with the general population sample.16 There 
is little direct evidence for the association between long- 
term alcohol consumption and ventricular arrhythmias, 
although it is postulated that adverse LV remodelling 
may play a role in the observed association between 
heavy alcohol consumption and sudden cardiac death.25 
Atrial fibrillation is the most common arrhythmia linked 
to the alcohol consumption,26 and the potential causal 
link between alcohol use and atrial fibrillation is well 
known for years and recently supported by evidence from 
a randomised controlled trial, which showed a reduction 
of atrial fibrillation recurrences after cessation of alcohol 
consumption by regular drinkers.27
We did not find changes in echocardiographic abnor-
malities in harmful and hazardous drinkers in the 
general population sample compared with non- problem 
drinkers. The number of people in these groups in our 
study was relatively small and thus we might be under-
powered to detect minor subclinical changes in these 
groups. Moreover, both the harmful and hazardous 
drinkers in the population- based sample had lower levels 
of two blood- based biomarkers (gamma- glutamyl trans-
ferase and carbohydrate- deficient transferrin) of heavy 
drinking than the narcology subsample participants 
(online supplemental table 1). However, NT- proBNP 
was elevated both in harmful drinkers as well as in the 
narcology clinic subsample as reported in our previous 
analysis of the KYH study.16
Among the potential mechanisms that are suggested to 
mediate the harmful action of alcohol on the heart are 
increased blood pressure and a direct effect of the toxic 
alcohol metabolites on the heart muscle. Blood pressure 
has a linear dose–response relationship with volume of 
alcohol consumed24 and is an established risk factor for 
CVD. Toxic alcohol metabolites affect heart muscle by 
increasing oxidative stress, triggering cell apoptosis.28 In 
our study, controlling for blood pressure in the regres-
sion model did not substantially change the estimates 
of the association between alcohol use and echocardio-
graphic abnormalities. This suggests that hypertension 
may not play a large role in mediating the relationship 
observed between heavy alcohol use and the echocardio-
graphic abnormalities observed.
Furthermore, the most consistent echocardiographic 
abnormality in our study was left ventricular dilatation, 
whereas hypertensive heart disease usually manifests as 
diastolic dysfunction and left ventricular hypertrophy. 
This, coupled with the lack of a strong mediating effect 
of hypertension, suggests that the primary abnormality 
related to heavy alcohol use is cardiomyopathy due to a 
direct toxic effect. Abnormal systolic function reflected 
by LV ejection fraction was detected in our study in 
the narcology clinic subsample, but diastolic function 
was not impaired. Thus, functional abnormalities are 
less prominent and may develop at a later pathological 
stage.
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Special populations
Limitations
There are inherent limitations to using echocardiog-
raphy compared with MRI due to higher measurement 
error for some echocardiographic indices.29 Also, esti-
mating right ventricular systolic pressure from tricuspid 
regurgitation velocity likely led to underestimation of 
diastolic dysfunction in our study. Therefore, we opted 
to assess the components of diastolic dysfunction (LA 
diameter, LA volume, e′ and E/e′) separately as contin-
uous variables. Although we observed an increased LA 
diameter in the narcology clinic sample compared with 
the general population sample, differences in LA volume 
between these two groups were not statistically signif-
icant after adjustment for confounders. This discrep-
ancy between two indices of LA size may be explained 
by high measurement error for biplane technique. The 
true differences are higher than observed in the studies 
of outcome variables characterised by high measurement 
error. Better characterisation of heart function would 
be possible with novel echocardiography techniques 
like global longitudinal strain measurement. They may 
be more sensitive to subtle changes that would not be 
detected with the conventional echocardiography tech-
niques. We cannot exclude that the results are affected 
by residual confounding by smoking or malnourishment 
in the narcology clinic subsample, as well as the effect of 
medication for detoxification after alcohol withdrawal in 
this group.
CONCLUSIONS
The characterisation of preclinical changes in heart 
structure and function in high- risk alcohol users provides 
insight about the link between alcohol use and cardio-
vascular mortality. One potential mechanism is alcohol- 
related dilated cardiomyopathy by toxic damage of the 
heart muscle. This could predispose to atrial fibrillation 
and consequently stroke or heart failure. Our results 
throw further light on some of the underlying mecha-
nisms that may help explain the observed associations 
between heavy drinking and cardiovascular mortality.
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